Teeft.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Chloroquine - Exploration (Accueil)

Index « Teeft.i » - entrée « Etoposide »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Etoh extracts < Etoposide < Etoposide bioavailability  Facettes :

List of bibliographic references indexed by Etoposide

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]
Ident.Authors (with country if any)Title
001B08 (2007) Reporting on Adverse Clinical Events
002235 (2002) Clin-Alert
002277 (2001) Ann H. Cory [États-Unis] ; Joseph G. Cory [États-Unis]Comparison of the properties of human breast cancer cells: mcf-7 and mcf-7 cells selected for resistance to etoposide
002476 (2000) Ronald D. Snyder [États-Unis]Use of catalytic topoisomerase II inhibitors to probe mechanisms of chemical‐induced clastogenicity in Chinese hamster V79 cells
002633 (1999) P. B. Jensen [Danemark] ; M. Sehested [Danemark] ; S. W. Langer [Danemark] ; H. H. Hansen [Danemark]Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratory
002773 (1998) Toshiwo Andoh [Japon] ; Ryoji Ishida [Japon]Catalytic inhibitors of DNA topoisomerase II
002948 (1997) Peter Buhl Jenen [Danemark] ; Maxwell Sehested [Danemark]DNA topoisomerase II rescue by catalytic inhibitors
002A06 (1996) Okezie I. Aruoma [Royaume-Uni]Characterization of drugs as antioxidant prophylactics
002A34 (1996) Maxwell Sehested [Danemark] ; Peter Buhl Jensen [Danemark]Mapping of DNA topoisomerase II poisons (etoposide, clerocidin) and catalytic inhibitors (aclarubicin, ICRF-187) to four distinct steps in the topoisomerase II catalytic cycle
002A39 (1996) B. Holm [Danemark] ; Peter Buhl Jensen [Danemark] ; Maxwell Sehested [Danemark]ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors
002A49 (1996) Susan F. Vervoordeldonk [Pays-Bas] ; Astrid Y. Balkenende [Pays-Bas] ; H. Van Den Berg ; A. E. G. Kr. Von Dem Borne ; C. E. Van Der Schoot [Pays-Bas] ; E. F. Van Leeuwen ; Ineke C. M. Slaper-Cortenbach [Pays-Bas] ; C. E. Van Der SchootDegradation of radioiodinated B cell monoclonal antibodies: inhibition via a FCγ -receptor-II-mediated mechanism and by drugs
002A76 (1995) Targeting the cytotoxicity of topoisomerase II-directed epipodophyllotoxins to tumor cells in acidic environments
002B06 (1995) Etoposide/ifosfamide/cisplatin regimens in metastatic non-small cell lung cancer
002B08 (1995) Dose-intensive ifosfamide/carboplatin/etoposide plus granulocyte-macrophage colony-stimulating factor for non-small cell lung cancer
002B18 (1995) Combination chemotherapy with vinorelbine, ifosfamide, and cisplatin: A phase II study in stage IIIB-IV non-small cell lung cancer
002B21 (1995) An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer
002C33 (1994) Induction of P-glycoprotein mediated MultiDrug resistance (Pgp-MDR) is associated with a decrease in ATP/P1, in vivo , whereas induction of altered topoisomerase MDR (at-MDR) is not - an in vivo 31P MR spectroscopic study of human SCLC tumor xenografts
002C35 (1994) In vitro evaluation of antimicrotubule agents in human small cell lung cancer (SCLC) cell lines
002C37 (1994) High dose etoposide (VP-16) combined with topoisomerase II antagonists. Models for differential protection of normal tissues versus tumor cells
002C39 (1994) Establishment and characterization of SN38 (An active metabolite of CPT-11)-resistant human small cell lung cancer (SCLC) cell line
003090 (1990) Gilda Civitico [Australie] ; Yanyan Wang [Australie] ; Carolyn Luscombe [Australie] ; Naomi Bishop [Australie] ; Gilda Tachedjian [Australie] ; Ian Gust [Australie] ; Stephen Locarnini [Australie]Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B Virus in vitro using conventional antiviral agents and supercoiled‐DNA active compounds

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Etoposide" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Etoposide" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Etoposide
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021